Reduction in the frequency of intravitreal bevacizumab administrations achieved by posterior subtenon injection of triamcinolone acetonide in patients with diffuse diabetic macular edema

被引：0
作者：
Masahiko Shimura
Kanako Yasuda
Teruumi Minezaki
Hidetaka Noma
机构：
[1] NTT East Japan Tohoku University Hospital,Department of Ophthalmology
[2] Tokyo Medical University,Department of Ophthalmology
[3] Hachioji Medical Center,undefined
来源：
Japanese Journal of Ophthalmology | 2016年 / 60卷
关键词：
Bevacizumab; Combination therapy; Diabetic macular edema; Subtenon injection; Triamcinolone acetonide;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：401 / 407
页数：6
相关论文
共 135 条
  • [1] Klein BE(2007)Overview of epidemiologic studies of diabetic retinopathy Ophthalmic Epidemiol 14 179-183
  • [2] Yau JW(2012)Global prevalence and major risk factors of diabetic retinopathy Diabetes Care 35 556-564
  • [3] Rogers SL(1994)Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1480-1487
  • [4] Kawasaki R(2012)New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel Eye (Lond). 26 485-493
  • [5] Lamoureux EL(2012)Diabetic macular edema Ophthalmologica. 227 21-29
  • [6] Kowalski JW(2007)Primary intravitreal bevacizumab (Avastin) for diabetic macular edema Ophthalmology 114 743-750
  • [7] Bek T(2006)Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema Retina. 26 999-1005
  • [8] Aiello LP(2012)Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE Ophthalmology 119 789-801
  • [9] Avery RL(2011)Intravitreal bevacizumab (Avastin) for diabetic retinopathy: the 2010 GLADAOF lecture J Ophthalmol. 2011 584238-400
  • [10] Arrigg PG(2009)Bevacizumab (Avastin) for the treatment of ocular disease Surv Ophthalmol 54 372-2562
12345678910